Related Experiment Videos
[Hyperhomocysteinemia in acute cerebral infarction]
Rebeca O Millán-Guerrero1, Clemente Vázquez, Lizette Isais-Aguilar
1Servicio de Neurología, Clínica HGZ UMF 1 IMSS, Colima.
Gaceta Medica De Mexico
|October 25, 2003
Summary
Elevated homocysteine levels were found in 59% of patients with acute cerebral infarction. This study did not find a link between high homocysteine and common risk factors for stroke.
Area of Science:
- Neurology
- Cardiovascular Science
- Metabolic Disorders
Context:
- Hyperhomocysteinemia is increasingly implicated in the arteriosclerotic processes underlying cerebral infarction.
- Understanding homocysteine's role in stroke is crucial for developing targeted interventions.
Purpose:
- To quantify plasmatic homocysteine levels in patients experiencing acute cerebral infarction.
- To investigate potential associations between homocysteine levels and clinical stroke subtypes or known risk factors.
Summary:
- This descriptive study analyzed 22 patients with acute cerebral infarction, measuring serum homocysteine levels.
- Elevated homocysteine was detected in 59% of patients (13 out of 22), with an average level of 20.68 mumol/l.
- No significant correlation was identified between hyperhomocysteinemia and clinical stroke characteristics or traditional risk factors like hypertension, diabetes, smoking, or alcoholism.
Impact:
- The findings highlight a high prevalence of hyperhomocysteinemia in acute cerebral infarction patients.
- Further research is needed to elucidate the specific factors contributing to elevated homocysteine and to develop strategies for its reduction.
- Lowering homocysteine levels may offer a novel approach to mitigating cerebrovascular disease incidence.